Pharmacists Regulation, B.C. Reg. 135/2025
Section 11
Definitions respecting drugs and devices
Cite as Pharmacists Regulation, B.C. Reg. 135/2025, s. 11 · last amended April 1, 2026 · read from BC Laws on November 17, 2026
The text
In sections 12 and 13:
“bylaw” includes a bylaw within the meaning of the Pharmacy Operations and Drug Scheduling Act;
“interchangeable drug” means a drug that, in relation to a drug referred to in a prescription,
(a) contains the same amount of the same active ingredients,
(b) possesses comparable pharmacokinetic properties,
(c) has the same clinically significant formulation characteristics, and
(d) is to be administered in the same way;
“program or protocol specifications” means the specifications established under either of the following:
(a) a therapeutic interchange program within the meaning of the Pharmacy Operations and Drug Scheduling Act that is approved by the governing body of a hospital or by the board;
(b) a protocol that
(i) is intended to optimize the therapeutic outcome of treatment with the drug or device referred to in a prescription, and
(ii) is approved by the governing body or board referred to in paragraph (a).
Read the Pharmacists Regulation on BC Laws ↗
Made under Health Professions and Occupations Act, SBC 2022, c. 43.